As of 2025-10-20, the Relative Valuation of CytomX Therapeutics Inc (CTMX) is 4.01 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.20 USD, the upside of CytomX Therapeutics Inc based on Relative Valuation is 25.2%.
The range of the Relative Valuation is 3.36 - 5.15 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 13.2x | 12.4x |
| Forward P/E multiples | 18.8x - 26.3x | 22.6x |
| Fair Price | 3.36 - 5.15 | 4.01 |
| Upside | 4.9% - 61.1% | 25.2% |
| Date | P/E |
| 2025-10-16 | 11.27 |
| 2025-10-15 | 11.72 |
| 2025-10-14 | 11.75 |
| 2025-10-13 | 11.69 |
| 2025-10-10 | 11.55 |
| 2025-10-09 | 11.86 |
| 2025-10-08 | 11.58 |
| 2025-10-07 | 11.44 |
| 2025-10-06 | 11.27 |
| 2025-10-03 | 11.34 |
| 2025-10-02 | 11.27 |
| 2025-10-01 | 11.51 |
| 2025-09-30 | 10.96 |
| 2025-09-29 | 11.10 |
| 2025-09-26 | 9.97 |
| 2025-09-25 | 9.76 |
| 2025-09-24 | 8.28 |
| 2025-09-23 | 7.25 |
| 2025-09-22 | 7.08 |
| 2025-09-19 | 6.80 |
| 2025-09-18 | 7.01 |
| 2025-09-17 | 6.63 |
| 2025-09-16 | 6.74 |
| 2025-09-15 | 6.84 |
| 2025-09-12 | 6.87 |
| 2025-09-11 | 7.18 |
| 2025-09-10 | 7.11 |
| 2025-09-09 | 7.18 |
| 2025-09-08 | 7.49 |
| 2025-09-05 | 7.84 |
| 2025-09-04 | 7.22 |
| 2025-09-03 | 7.29 |
| 2025-09-02 | 7.15 |
| 2025-08-29 | 7.01 |
| 2025-08-28 | 7.05 |
| 2025-08-27 | 7.11 |
| 2025-08-26 | 6.98 |
| 2025-08-25 | 6.87 |
| 2025-08-22 | 7.29 |
| 2025-08-21 | 6.98 |
| 2025-08-20 | 6.77 |
| 2025-08-19 | 6.87 |
| 2025-08-18 | 7.29 |
| 2025-08-15 | 6.56 |
| 2025-08-14 | 6.05 |
| 2025-08-13 | 6.10 |
| 2025-08-12 | 6.39 |
| 2025-08-11 | 7.94 |
| 2025-08-08 | 8.08 |
| 2025-08-07 | 7.22 |